跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Uphadyl Forte Expectorant - NPRA Drug Approval Details
Approvals
/
NPRA
/
Uphadyl Forte Expectorant
Approved
STANDARD
Uphadyl Forte Expectorant
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
01546c5606f570db
Company
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Type
Standard
Approval Details
Approval Id
01546c5606f570db
Drug Approval Npra Name
Uphadyl Forte Expectorant
Product Name
Uphadyl Forte Expectorant
Registration Number
MAL22096019AZ
Holder Company Name
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Holder Address
LOT NO. 2, 4, 6, 8 & 10, JALAN P/7 SECTION 13, BANGI INDUSTRIAL ESTATE 43650 BANDAR BARU BANGI MALAYSIA
Holder Phone
03-89242188
Manufacturer Company Name
DUOPHARMA MANUFACTURING (BANGI) SDN. BHD.
Manufacturer Address
LOT NO. 2 & 4, JALAN P/7 SECTION 13, BANGI INDUSTRIAL ESTATE 43650 BANDAR BARU BANGI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL22096019AZ
Version
1751614514
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
01546c5606f570db
Type
Standard
Source
Official Source
Back to NPRA Approvals